Treatment Adherence among Persons Receiving Concurrent Multidrug-Resistant Tuberculosis and Human Immunodeficiency Virus Treatment in KwaZulu-Natal, South Africa

Background:Success in multidrug-resistant tuberculosis (MDR-TB) and HIV treatment requires high medication adherence despite high pill burdens, frequent adverse events, and long treatment duration, which may jeopardize adherence. We prospectively compared MDR-TB/HIV-coinfected persons to those with